Chemaphor Announces Option Grants

Friday, 27 April 2012 04:15 PM

OTTAWA, April 27, 2012 - Chemaphor Inc. (TSXV: CFR) today announced pursuant to the requirements of the TSX Venture Exchange, that it has granted options to purchase 96,000 common shares to outside members of its board of directors. The stock options were granted pursuant to the terms of Chemaphor's stock option plan and are exercisable at $0.10 per share. These grants form part of a total annual remuneration package for board members. Stock option grants are subject to necessary regulatory approvals.

About Chemaphor

Chemaphor, a wellness company, is committed to developing and delivering products for animals and humans to assist in optimizing health and daily quality of life. Chemaphor is advancing product candidates for the food animal market, companion animal market and various potential human applications. More information can be found at www.chemaphor.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information:

David HankinsonGraham Burton, PhD

CEO, Chemaphor Inc.President and Co-Founder, Chemaphor Inc.

Phone: 902-825-9270Phone: 613-990-0969

[email protected]@chemaphor.com